Polymeric immunoglobulin receptor expression is correlated with poor prognosis in patients with osteosarcoma

Molecular Medicine Reports

Volumn 9, Issue 6, 2014, Pages 2105-2110

  Wang, Xuanwei ^a   Du, Jingyu ^a   Gu, Pengcheng ^a   Jin, Rilong ^a   Lin, Xiangjin ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Osteosarcoma; Polymeric immunoglobulin receptor; Prognosis

Indexed keywords

SECRETORY COMPONENT; MESSENGER RNA;

ADULT; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DISTANT METASTASIS; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; OSTEOSARCOMA; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; ADOLESCENT; FOLLOW UP; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MORTALITY; PROGNOSIS; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; OSTEOSARCOMA; PROGNOSIS; RECEPTORS, POLYMERIC IMMUNOGLOBULIN; RNA, MESSENGER; YOUNG ADULT;

EID: 84899667077     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2110     Document Type: Article

References (29)

1. Ma O, Cai WW, Zender L, Dayaram T, Shen J, Herron AJ, Lowe SW, Man TK, Lau CC and Donehower LA: MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression. Cancer Res 69: 2559-2567, 2009.
2. Janeway KA and Grier HE: Sequelae of osteosarcoma medical therapy: a review of rare acute toxicities and late effects. Lancet Oncol 11: 670-678, 2010.
3. Caudill JS and Arndt CA: Diagnosis and management of bone malignancy in adolescence. Adolesc Med State Art Rev 18: 62-78, 2007.
4. Bacci G, Rocca M, Salone M, Balladelli A, Ferrari S, Palmerini E, Forni C and Briccoli A: High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions. J Surg Oncol 98: 415-420, 2008.
5. Bielack SS, Kempf-Bielack B, Delling G, Exner GU, Flege S, Helmke K, Kotz R, Salzer-Kuntschik M, Werner M, Winkelmann W, et al: Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 20: 776-790, 2002. (Pubitemid 34111386)
6. Errani C, Longhi A, Rossi G, Rimondi E, Biazzo A, Toscano A, Alì N, Ruggieri P, Alberghini M, Picci P, et al: Palliative therapy for osteosarcoma. Expert Rev Anticancer Ther 11: 217-227, 2011.
7. Denning GM: IL-4 and IFN-gamma synergistically increase total polymeric IgA receptor levels in human intestinal epithelial cells. Role of protein tyrosine kinases. J Immunol 156: 4807-4814, 1996.
8. Kvale D, Løvhaug D, Sollid LM and Brandtzaeg P: Tumor necrosis factor-alpha up-regulates expression of secretory component, the epithelial receptor for polymeric Ig. J Immunol 140: 3086-3089, 1988.
9. Rojas R and Apodaca G: Immunoglobulin transport across polarized epithelial cells. Nat Rev Mol Cell Biol 3: 944-955, 2002. (Pubitemid 35477372)
10. Kaetzel CS: The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces. Immunol Rev 206: 83-99, 2005.
11. Poger ME, Hirsch BR and Lamm ME: Synthesis of secretory component by colonic neoplasms. Am J Pathol 82: 327-338, 1976.
12. Harris JP, Caleb MH and South MA: Secretory component in human mammary carcinoma. Cancer Res 35: 1861-1864, 1975.
13. Harris JP and South MA: Secretory component: a glandular epithelial cell marker. Am J Pathol 105: 47-53, 1981. (Pubitemid 11018493)
14. DeSouza LV, Krakovska O, Darfler MM, Krizman DB, Romaschin AD, Colgan TJ and Siu KW: mTRAQ-based quantification of potential endometrial carcinoma biomarkers from archived formalin-fixed paraffin-embedded tissues. Proteomics 10: 3108-3116, 2010.
15. DeSouza LV, Romaschin AD, Colgan TJ and Siu KW: Absolute quantification of potential cancer markers in clinical tissue homogenates using multiple reaction monitoring on a hybrid triple quadrupole/linear ion trap tandem mass spectrometer. Anal Chem 81: 3462-3470, 2009.
16. Rossel M, Billerey C, Bittard H, Ksiazek P, Alber D, Revillard JP and Vuitton DA: Alterations in polymeric immunoglobulin receptor expression and secretory component levels in bladder carcinoma. Urol Res 19: 361-366, 1991.
17. Rossel M, Seilles E, Voigt JJ, Vuitton D, Legait N and Revillard JP: Polymeric Ig receptor expression in hepatocellular carcinoma. Eur J Cancer 28A: 1120-1124, 1992.
18. Ai J, Tang Q, Wu Y, Xu Y, Feng T, Zhou R, Chen Y, Gao X, Zhu Q, Yue X, et al: The role of polymeric immunoglobulin receptor in inflammation-induced tumor metastasis of human hepatocellular carcinoma. J Natl Cancer Inst 103: 1696-1712, 2011.
19. Xiao T, Ying W, Li L, Hu Z, Ma Y, Jiao L, Ma J, Cai Y, Lin D, Guo S, et al: An approach to studying lung cancer-related proteins in human blood. Mol Cell Proteomics 4: 1480-1486, 2005. (Pubitemid 41555474)
20. Rossel M, Brambilla E, Billaud M, Vuitton DA, Blanc-Jouvan F, Biichle S and Revillard JP: Nonspecific increased serum levels of secretory component in lung tumors: relationship to the gene expression of the transmembrane receptor form. Am J Respir Cell Mol Biol 9: 341-346, 1993.
21. Makawita S, Smith C, Batruch I, Zheng Y, Rückert F, Grützmann R, Pilarsky C, Gallinger S and Diamandis EP: Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers. Mol Cell Proteomics 10: M111.008599, 2011.
22. Kvale D, Norstein J, Meling GI, Børmer OP, Brandtzaeg P, Langmark F and Rognum TO: Circulating secretory component in relation to early diagnosis and treatment of liver metastasis from colorectal carcinomas. J Clin Pathol 45: 568-571, 1992.
23. Enneking WF, Spanier SS and Goodman MA: A system for the surgical staging of musculoskeletal sarcoma. 1980. Clin Orthop Relat Res 415: 4-18, 2003.
24. Bruno ME and Kaetzel CS: Long-term exposure of the HT-29 human intestinal epithelial cell line to TNF causes sustained up-regulation of the polymeric Ig receptor and proinflammatory genes through transcriptional and posttranscriptional mechanisms. J Immunol 174: 7278-7284, 2005. (Pubitemid 40705697)
25. Khattar NH, Lele SM and Kaetzel CS: Down-regulation of the polymeric immunoglobulin receptor in non-small cell lung carcinoma: correlation with dysregulated expression of the transcription factors USF and AP2. J Biomed Sci 12: 65-77, 2005. (Pubitemid 40576765)
26. Laverdiere C, Hoang BH, Yang R, Sowers R, Qin J, Meyers PA, Huvos AG, Healey JH and Gorlick R: Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma. Clin Cancer Res 11: 2561-2567, 2005. (Pubitemid 40569454)
27. Urakawa H, Nishida Y, Nakashima H, Shimoyama Y, Nakamura S and Ishiguro N: Prognostic value of indoleamine 2,3-dioxygenase expression in high grade osteosarcoma. Clin Exp Metastasis 26: 1005-1012, 2009.
28. Eccles SA and Welch DR: Metastasis: recent discoveries and novel treatment strategies. Lancet 369: 1742-1757, 2007. (Pubitemid 46755391)
29. Mestecky J and McGhee JR: Immunoglobulin A (IgA): molecular and cellular interactions involved in IgA biosynthesis and immune response. Adv Immunol 40: 153-245, 1987. (Pubitemid 17099007)